Combination Therapies and Personalized Medicine
Dosage Regimen: Individualization
Bioavailability Study Design: Healthy Subjects Versus Patients
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 18, 2026

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Sundeep Khosla1,2, David G Monroe3,4, Joshua N Farr5
1Division of Endocrinology, Mayo Clinic, Rochester, MN, USA. Khosla.sundeep@mayo.edu.
No abstract available in PubMed .
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
08:56Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022